Wockhardt Limited – NSE:WOCKPHARMA.NS
Wockhardt Limited stock price today
Wockhardt Limited stock price monthly change
Wockhardt Limited stock price quarterly change
Wockhardt Limited stock price yearly change
Wockhardt Limited key metrics
Market Cap | 233.82B |
Enterprise value | 44.18B |
P/E | -3.61 |
EV/Sales | 1.68 |
EV/EBITDA | -34.88 |
Price/Sales | 0.91 |
Price/Book | 0.68 |
PEG ratio | 0.02 |
EPS | -32.13 |
Revenue | 27.98B |
EBITDA | 1.91B |
Income | -4.63B |
Revenue Q/Q | 3.24% |
Revenue Y/Y | 5.54% |
Profit margin | -23.22% |
Oper. margin | -7.65% |
Gross margin | 58.91% |
EBIT margin | -7.65% |
EBITDA margin | 6.83% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeWockhardt Limited stock price history
Wockhardt Limited stock forecast
Wockhardt Limited financial statements
| Jun 2023 | 6.44B | -1.34B | -20.81% |
|---|---|---|---|
| Sep 2023 | 7.53B | -770M | -10.23% |
| Dec 2023 | 7.01B | -830M | -11.84% |
| Mar 2024 | 7B | -1.69B | -24.14% |
| Payout ratio | 0% |
|---|
| 2016 | 0% |
|---|---|
| 2017 | 1.6% |
| 2019 | 0% |
| 2020 | |
| 2022 | 0.06% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 74200000000 | 39.88B | 53.75% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 76490000000 | 39.87B | 52.12% |
| Mar 2023 | 10M | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 1.1B | 0 | 0 |
| Sep 2023 | 1.1B | 0 | 0 |
| Dec 2023 | 1.1B | 0 | 0 |
Wockhardt Limited alternative data
| Aug 2023 | 5,000 |
|---|---|
| Sep 2023 | 2,740 |
| Oct 2023 | 2,740 |
| Nov 2023 | 2,740 |
| Dec 2023 | 2,740 |
| Jan 2024 | 2,740 |
| Feb 2024 | 2,740 |
| Mar 2024 | 2,740 |
| Apr 2024 | 2,740 |
| May 2024 | 2,740 |
| Jun 2024 | 2,740 |
| Jul 2024 | 2,386 |
Wockhardt Limited other data
| Insider | Compensation |
|---|---|
Dr. Habil Fakhruddin Khorakiwala (1941) Founder & Executive Chairman | $28,000,000 |
Dr. Huzaifa Habil Khorakiwala (1971) Executive Director | $24,000,000 |
Dr. Murtaza Habil Khorakiwala (1973) MD & Executive Director | $24,000,000 |
-
What's the price of Wockhardt Limited stock today?
One share of Wockhardt Limited stock can currently be purchased for approximately $412.85.
-
When is Wockhardt Limited's next earnings date?
Unfortunately, Wockhardt Limited's (WOCKPHARMA.NS) next earnings date is currently unknown.
-
Does Wockhardt Limited pay dividends?
No, Wockhardt Limited does not pay dividends.
-
How much money does Wockhardt Limited make?
Wockhardt Limited has a market capitalization of 233.82B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 13.12% to 27.89B US dollars.
-
What is Wockhardt Limited's stock symbol?
Wockhardt Limited is traded on the NSE under the ticker symbol "WOCKPHARMA.NS".
-
What is Wockhardt Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Wockhardt Limited?
Shares of Wockhardt Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Wockhardt Limited's key executives?
Wockhardt Limited's management team includes the following people:
- Dr. Habil Fakhruddin Khorakiwala Founder & Executive Chairman(age: 84, pay: $28,000,000)
- Dr. Huzaifa Habil Khorakiwala Executive Director(age: 54, pay: $24,000,000)
- Dr. Murtaza Habil Khorakiwala MD & Executive Director(age: 52, pay: $24,000,000)
-
Is Wockhardt Limited founder-led company?
Yes, Wockhardt Limited is a company led by its founder Dr. Habil Fakhruddin Khorakiwala.
-
How many employees does Wockhardt Limited have?
As Jul 2024, Wockhardt Limited employs 2,386 workers, which is 13% less then previous month and 13% less then previous quarter.
-
When Wockhardt Limited went public?
Wockhardt Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.
-
What is Wockhardt Limited's official website?
The official website for Wockhardt Limited is wockhardt.com.
-
How can i contact Wockhardt Limited?
Wockhardt Limited can be reached via phone at +91 240 669 4444.
Wockhardt Limited company profile:
Wockhardt Limited
wockhardt.comNSE
2,386
Drug Manufacturers - Specialty & Generic
Healthcare
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. It also provides contract manufacturing services for sterile injectables, lyophilization, and other dosage forms; and research services. The company was founded in 1967 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
Mumbai, 400051
:
ISIN: INE049B01025
CUSIP: Y73505136
